Organigram Beats in Fiscal Q1, Stock Soars, But For How Long? Organigram Holdings was sharply higher yesterday after reporting its fiscal Q1 2020. But with negligible revenue growth over the past two quarters, is that gain sustainable?

Quebec’s provincial government suffers from acute anti-cannabis paranoia. Chicken Little pseudo-science like this doesn’t help.

Former Vice President Joe Biden reaffirmed that he’s opposed to legalizing marijuana without further studying its potential health risks.

This is The Seed Investor’s weekly wrap up of major news from the cannabis industry and our analysis of the important trends.

Diet. Detox. Paleo. Parisian. Whatever you want to call it, nearly half of Canadians are following some sort of food plan to lose weight, according to a recent national poll.

At a congressional hearing on Wednesday, federal regulators recognized that valuable research into MJ is being inhibited CB’s current legal status and described previously unreported steps they’re taking to resolve the issue.

The largest U.S.-based cannabis company and the largest Canadian cannabis company have both seen their stock make strong moves. Will other cannabis companies follow?

Organigram Holdings was sharply higher yesterday after reporting its fiscal Q1 2020. But with negligible revenue growth over the past two quarters, is that gain sustainable?

Montana took a first step towards putting cannabis legalization on the November 2020 ballot this afternoon, as New Approach Montana submitted two ballot initiatives to the state attorney general’s office for legal vetting.

The head of the nation’s only federally approved marijuana farm has revealed that he is developing cannabis eye drops to treat glaucoma.